Anti-Tuberculosis Activity of Three Carbapenems, Clofazimine and Nitazoxanide Using a Novel Ex Vivo Phenotypic Drug Susceptibility Model of Human Tuberculosis. (2022)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/antibiotics11101274

PubMed Identifier: 36289932

Publication URI: http://europepmc.org/abstract/MED/36289932

Type: Journal Article/Review

Volume: 11

Parent Publication: Antibiotics (Basel, Switzerland)

Issue: 10

ISSN: 2079-6382